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Background: Dopaminergic fibers originating from area A11 of the hypothalamus project to different levels of the
spinal cord and represent the major source of dopamine. In addition, tyrosine hydroxylase, the rate-limiting enzyme
for the synthesis of catecholamines, is expressed in 8-10% of dorsal root ganglia (DRG) neurons, suggesting that
dopamine may be released in the dorsal root ganglia. Dopamine has been shown to modulate calcium current in
DRG neurons, but the effects of dopamine on sodium current and on the firing properties of small DRG neurons
are poorly understood.
Results: The effects of dopamine and dopamine receptor agonists were tested on the tetrodotoxin-resistant (TTX-R)
sodium current recorded from acutely dissociated small (diameter ≤ 25 μm) DRG neurons. Dopamine (20 μM) and
SKF 81297 (10 μM) caused inhibition of TTX-R sodium current in small DRG neurons by 23% and 37%, respectively.
In contrast, quinpirole (20 μM) had no effects on the TTX-R sodium current. Inhibition by SKF 81297 of the TTX-R
sodium current was not affected when the protein kinase A (PKA) activity was blocked with the PKA inhibitory
peptide (6–22), but was greatly reduced when the protein kinase C (PKC) activity was blocked with the PKC
inhibitory peptide (19–36), suggesting that activation of D1/D5 dopamine receptors is linked to PKC activity.
Expression of D1and D5 dopamine receptors in small DRG neurons, but not D2 dopamine receptors, was confirmed
by Western blotting and immunofluorescence analysis. In current clamp experiments, the number of action
potentials elicited in small DRG neurons by current injection was reduced by ~ 30% by SKF 81297.
Conclusions: We conclude that activation of D1/D5 dopamine receptors inhibits TTX-R sodium current in
unmyelinated nociceptive neurons and dampens their intrinsic excitability by reducing the number of action
potentials in response to stimulus. Increasing or decreasing levels of dopamine in the dorsal root ganglia may serve
to adjust the sensitivity of nociceptors to noxious stimuli.
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Small DRG neurons with unmyelinated axons signal
nociceptive sensory information from the body surface
and viscera to the dorsal spinal horn. Small DRG
neurons are unusual in expressing both tetrodotoxin-
sensitive (TTX-S) (NaV1.1, NaV1.2, NaV1.6, and NaV1.7)
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stated.channels [1-9]. NaV1.8 and NaV1.9 channels are prefe-
rentially expressed in small DRG neurons and fulfill critical
aspects of their physiology [10-14]. In addition to their
contribution to different aspects of pain [15-21], NaV1.8
channels play a major role during the upstroke of the ac-
tion potential in small DRG neurons [14,22,23], and thus
represent an ideal target for neuromodulators to affect
their intrinsic excitability.
Dopaminergic fibers from area A11 of the hypotha-
lamus project to different levels of the spinal cord and
represent the major source of dopamine [24-28]. A func-
tional role of dopamine in the spinal cord is suggested
by: i) expression of D1-D5 dopamine receptors [29-31];l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Galbavy et al. Molecular Pain 2013, 9:60 Page 2 of 15
http://www.molecularpain.com/content/9/1/60ii) peripheral nocifensive action of dopamine [32-37]; iii)
post-synaptic effects of dopamine in the dorsal spinal
horn that can inhibit nociceptive transmission [38,39].
In addition to descending dopaminergic fibers from
the hypothalamus, several subpopulations of DRG neu-
rons, including those specialized in detecting low-
threshold mechanosensory stimuli and those innervating
pelvic organs, express tyrosine hydroxylase (TH), the
rate-limiting enzyme for the synthesis of catecholamines,
and thus most likely release dopamine as a modulatory
transmitter [40-45]. Cultured DRG neurons release var-
ious peptides and ATP from their soma [46-48], sugges-
ting that they may also release dopamine as well [49].
Dopamine has been shown to modulate calcium cur-
rent in DRG neurons [50-52], but the effects of dopamine
on sodium current and on the intrinsic excitability of
small DRG neurons are poorly understood. Despite some
reports showing inhibition of sodium current in chick sen-
sory neurons [50], intracellular recordings from DRG neu-
rons in isolated spinal ganglia have reported contrasting
results showing depolarization, hyperpolarization or bi-
phasic responses of the cell membrane upon application
of dopamine [53-55].
Here, using an in vitro preparation of acutely disso-
ciated DRG neurons, we show that dopamine inhibits
the TTX-R sodium current in small DRG neurons and
dampens their intrinsic excitability. Pharmacological
studies indicate that the effect of dopamine is mediated
by D1/D5 dopamine receptors.
Results
Dopamine effect on TTX-resistant sodium current
Small DRG neurons express both TTX-S and TTX-R so-
dium channels. In order to isolate the TTX-R sodium
current, TTX-S sodium current was blocked by 300 nM
TTX in the presence of 30 μM Cd2+ to block calcium
current. The inward current remaining in 300 nM TTX
was completely blocked when 151 mM NaCl was replaced
with equimolar tetraethylammonium-Cl (Figure 1A). Tet-
rodotoxin (300 nM) was only a weak inhibitor of the
total sodium current, reducing the peak by 19.6 ± 14.0%
(n = 32), similar to previous reports in small DRG neurons
[9,23]. The TTX-R sodium current isolated with this
protocol (Figure 1B) is consistent with sodium current
carried through NaV1.8 channels previously reported in
small DRG neurons [1-5,56]. At the holding potential
of −80 mV, there was no obvious component of non-
inactivating current from NaV1.9 channels. The TTX-R
sodium current recorded with this protocol was quite
stable over 20–25 min (Figure 1C). In collected results
(Figure 1D,E), the TTX-R sodium current showed no
significant decrease during 25 min, changing from
1.01 ± 0.03 (normalized peak) during the first 5 min to
0.97 ± 0.04 after 25 min (n = 11, paired t-test, p = 0.104).We next used this same protocol to test the effect of
dopamine on TTX-R sodium current. After 5 min in con-
trol, the neuron was challenged with 20 μM dopamine
(Figure 1F). Dopamine caused a clear inhibition of TTX-R
sodium current. In collected results (Figure 1G,H), the
TTX-R sodium current was reduced from 0.99 ± 0.01 to
0.77 ± 0.09 (n = 7, paired t-test, **p < 0.01) after 15 min in
20 μM dopamine.
Effect of SKF 81297 on TTX-R sodium current
The next step was to identify which dopamine receptors
mediate this inhibitory effect. The D1/D5 receptor agonist
SKF 81297 produced inhibition very much like that of
dopamine (Figure 2A). In collected results (Figure 2B,C),
the TTX-R sodium current was reduced from 0.99 ± 0.02
to 0.63 ± 0.08 (n = 22, paired t-test, **p < 0.01) after 15 min
in 10 μM SKF 81297. In contrast, the D2 receptor agonist
quinpirole had no significant effect (Figure 2D); in col-
lected results (Figure 2E,F), the TTX-R sodium current
was reduced from 0.99 ± 0.01 to 0.94 ± 0.04 (n = 5, paired
t-test, p = 0.065) after 15 min in 20 μM quinpirole. These
results strongly suggest that the inhibitory effect of dopa-
mine on TTX-R sodium current in small DRG neurons is
mediated by activation of D1/D5 dopamine receptors.
To test this further, we used SCH 23390, a selective
antagonist at D1/D5 dopamine receptors [57,58]. As
expected, the effect of SKF 81297 (Figure 3A, black
circles) was antagonized by SCH 23390 (Figure 3A, blue
squares). Similarly, the effect of SKF 81297 was also
reduced by the alkylating agent ethoxycarbonyl-2-
ethoxy-1,2-dihydroquinoline (EEDQ), a broad, irreversible,
dopamine receptor antagonist [Figure 3A, 20 μM EEDQ
(red triangles) and 100 μM EEDQ (green diamonds)]. In
collected results (Figure 3B), the inhibitory effect of
10 μM SKF 81297 on TTX-R sodium current was reduced
from 0.63 ± 0.08 (n = 22) when applied without the antag-
onist (black bars) to 0.83 ± 0.04 (n = 8, one-way ANOVA,
followed by Dunnett post-hoc analysis **p < 0.01) when
applied in combination with 3 μM SCH 23390 (blue bars);
to 0.79 ± 0.06 (n = 6, one-way ANOVA, followed by
Dunnett post-hoc analysis, **p < 0.01) when applied in
combination with 20 μM EEDQ (red bars); to 0.92 ± 0.07
(n = 9, one-way ANOVA, followed by Dunnett post-hoc
analysis, **p < 0.01) when applied in combination with
100 μM EEDQ (green bars).
Intracellular pathways downstream to D1/D5 dopamine
receptors
Previous work has described the ability of PKA and PKC
to modulate both TTX-S sodium current in central
neurons [57-59] and TTX-R sodium current in periph-
eral sensory neurons [60-65]. When PKA activity was
blocked by including in the patch pipette 10 μM of PKA
inhibitory fragment (6–22) [PKAi(6–22)], the inhibitory
Figure 1 Dopamine effect on TTX-R sodium current. A) Isolation of TTX-R sodium current from a small DRG neuron (diameter≤ 25 μm). Top:
voltage clamp protocol. A single step of voltage from −80 to 0 mV, 30 msec duration, was delivered every 5 sec. Bottom: Total sodium current
(Total INa) recorded in Tyrode’s solution supplemented with 30 μM CdCl2 to block calcium current. Subsequent application of 300 nM tetrodotoxin
blocked the TTX-S sodium current leaving only the TTX-R sodium current which was completely blocked when 151 mM NaCl was replaced by
equimolar concentration of tetraethylammonium-Cl. B) TTX-S and TTX-R sodium currents isolated by subtraction from the cell in A. C) The TTX-R
sodium current recorded in a small DRG neuron was normalized to the peak TTX-R sodium current recorded during the first 5 min in whole-cell
and monitored for 25 min. D) Collected results showing the relative peak of TTX-R sodium current during 25 min. E) The relative peak of TTX-R
sodium current was 1.01 ± 0.03 at 5 min and 0.97 ± 0.04 at 25 min (n = 11, paired t-Test, p = 0.104). F) In a small DRG neuron, 20 μM dopamine
reduced the relative peak of TTX-R sodium current from 0.99 (after 5 min in control) to 0.75 (after 15 min in 20 μM dopamine). G) Collected
results showing the effect of 20 μM dopamine on the relative peak of TTX-R sodium current. H) The relative peak of TTX-R sodium current was
reduced from 0.99 ± 0.01 after 5 min in control to 0.77 ± 0.09 (n = 7, paired t-test, **p < 0.01) after 15 min in 20 μM dopamine.
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Figure 2 Effect of D1/D5 and D2 dopamine receptor agonists on TTX-R sodium current. A) In a small DRG neuron (diameter≤ 25 μm),
10 μM SKF 81297 (D1/D5 dopamine receptors agonist) reduced the relative peak of TTX-R sodium current from 0.97 after 5 min in control to 0.51
after 15 min in SKF 81297. Inset: representative TTX-R sodium current traces recorded after 5 min in control (trace 1), after 15 min in 10 μM SKF
81297 (trace 2), and after 5 min washout (trace 3). B) Collected results showing the effect of 10 μM SKF 81297 on the relative peak of TTX-R
sodium current. C) The relative peak of TTX-R sodium current was reduced from 0.99 ± 0.02 after 5 min in control to 0.63 ± 0.08 (n = 22, paired
t-Test, **p < 0.01) after 15 min in 10 μM SKF 81297. D) In a small DRG neuron, 20 μM quinpirole (D2 dopamine receptor agonist) caused only a
little change on the relative peak of TTX-R sodium current from 0.97 after 5 min in control to 0.94 after 15 min in 20 μM quinpirole. E) Collected
results showing the effect of 20 μM quinpirole on the relative peak of TTX-R sodium current. F) The relative peak of TTX-R sodium current was
reduced from 0.99 ± 0.01 after 5 min in control to 0.94 ± 0.04 (n = 5, paired t-test, p = 0.065) after 15 min in 20 μM quinpirole.
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small DRG neurons was unaffected. In collected re-
sults (Figure 4A,B), the TTX-R sodium current was
reduced from 0.99 ± 0.01 to 0.63 ± 0.08 (n = 22) after
15 min in 10 μM SKF 81297 (Figure 4A, circles) and
from 0.99 ± 0.01 to 0.66 ± 0.06 (n = 11, t-test, two pop-
ulations, p = 0.229) after 15 min in 10 μM SKF 81297
with 10 μM PKAi(6–22) included in the patch pipette
(Figure 4A, squares).
In contrast, when PKC activity was blocked by inclu-
ding in the patch pipette 5 μM of PKC inhibitory frag-
ment (19–36) [PKCi(19–36)], the inhibitory effect of
10 μM SKF 81297 on the TTX-R sodium current was
substantially affected. In collected results (Figure 4C,D),the TTX-R sodium current was reduced from 0.99 ± 0.01
to 0.63 ± 0.08 (n = 22) after 15 min in 10 μM SKF 81297
(Figure 4C, circles) and from 0.99 ± 0.01 to 0.78 ± 0.06
(n = 11, t-test, two populations, **p < 0.01) after 15 min
in 10 μM SKF 81297 with 5 μM of PKCi(19–36) in-
cluded in the patch pipette (Figure 4C, triangles). Taken
together, these results suggest that activation of D1/D5
dopamine receptors in small DRG neurons is coupled to
PKC activity.
Effect of SKF 81297 on steady-state activation and
inactivation curves of TTX-R sodium channels
We next tested whether D1/D5 dopamine receptors
inhibition of TTX-R sodium channels is mediated by
Figure 3 The effect of SKF 81297 (D1/D5 dopamine receptors agonist) on TTX-R sodium current was antagonized by SCH 23390 and
EEDQ. A) Collected results showing the effect of 10 μM SKF 81297 on TTX-R sodium current applied either alone (black circles), or in combination
with 3 μM SCH 23390 (blue squares), or 20 μM EEDQ (red triangles), or 100 μM EEDQ (green diamonds). B) The inhibitory effect of 10 μM SKF
81297 on the relative peak of TTX-R sodium current was reduced from 0.63 ± 0.08 (n = 22) when applied without the antagonist (black bars) to
0.83 ± 0.04 (n = 8, one-way ANOVA, followed by post-hoc Dunnett analysis **p < 0.01) when applied on DRG neurons incubated for 15 min with
3 μM SCH 23390 (blue bars); to 0.79 ± 0.06 (n = 6, one-way ANOVA, followed by post-hoc Dunnett analysis **p < 0.01) when applied on DRG
neurons incubated for 30 min with 20 μM EEDQ (red bars); to 0.92 ± 0.07 (n = 9, one-way ANOVA, followed by post-hoc Dunnett analysis,
**p < 0.01) when applied on DRG neurons incubated for 30 min with 100 μM EEDQ (green bars).
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activation of the channels. The steady-state activation
curve had a midpoint of −15.1 ± 4.2 mV and a slope of
5.0 ± 1.8 mV (n = 17) in control (Figure 5C, circles) ver-
sus −12.7 ± 7.4 mV (t-test, two populations, p = 0.270)
and 4.9 ± 2.1 mV (n = 15) in 10 μM SKF 81297 (Figure 5C,
diamonds). The steady-state inactivation curve had a
midpoint of −34.7 ± 3.2 mV and a slope of 4.9 ± 1.1 mV
(n = 17) in control (Figure 5D, circles) versus −31.3 ±
4.2 mV (t-test, two populations, *p < 0.05) and 5.2 ±
1.9 mV (n = 15) in 10 μM SKF 81297 (Figure 5D, dia-
monds). The changes induced by SKF 81297 on the
steady-state activation and inactivation curves of TTX-R
sodium channels are similar to previously reported effects
of D1/D5 dopamine receptors activation on TTX-S so-
dium channels both in central neurons [57-59] and in re-
tinal ganglion cells [66].
Effect of SKF 81297 on firing
The TTX-R sodium current plays a major role during
the upstroke of the action potential in small DRG neu-
rons [14,22,23], and thus may represent an ideal targetfor neuromodulators to induce changes in the intrinsic
excitability of nociceptors. In order to test this hypoth-
esis, the effect of SKF 81297 was assessed in current
clamp in which trains of action potentials were elicited
in small DRG neurons by current injection [56]. During
the initial control experiments in current clamp, we ob-
served a progressive reduction in the number of action
potentials elicited with repeated current injections. The
number of action potentials decreased from 15.3 ± 3.8
(n = 6) during the first ramp to 9.8 ± 2.5 (n = 6) during
the fifth ramp, even with 30 sec interval between current
injections, possibly reflecting accumulation of slow in-
activation of sodium channels during sustained depo-
larization [56]. For this reason, we decided to limit the
analysis to action potentials elicited during the first
current injection by making a comparison between small
DRG neurons in control to those incubated with 10 μM
SKF 81297 for 15 min (Figure 6A,B). The resting po-
tential of small DRG neurons in control (−73.6 ± 4.9 mV,
n = 15) was very similar to the resting potential of small
DRG neurons incubated for 15 min in 10 μM SKF
81297 (−73.7 ± 5.0 mV, n = 12, t-test, two populations,
Figure 4 Intracelluar pathway downstream to D1/D5 dopamine
receptors activation. A) Collected results showing the effect of
10 μM SKF 81297 on TTX-R sodium current applied either alone
(circles) or in combination with 10 μM PKAi(6–22) (squares) included
in the patch pipette to block the PKA activity. B) The inhibitory effect
of 10 μM SKF 81297 on the relative peak of TTX-R sodium current
was slightly reduced from 0.63 ± 0.08 (n = 22) when applied alone to
0.66 ± 0.06 (n = 11, t-test, two populations, p = 0.229) when applied
in combination with 10 μM PKAi(6–22) included in the patch pipette.
C) Collected results showing the effect of 10 μM SKF 81297 on
TTX-R sodium current applied either alone (circles) or in combination
with 5 μM PKCi(19–36) (triangles) included in the patch pipette to
block the PKC activity. D) The inhibitory effect of 10 μM SKF 81297
on the relative peak of TTX-R sodium current was significantly
reduced from 0.63 ± 0.08 (n = 22) when applied alone to 0.78 ± 0.06
(n = 11, t-test, two populations, **p < 0.01) when applied in
combination with 5 μM of PKCi(19–36) included in the patch pipette.
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the first current injection decreased from 14.9 ± 3.4
(n = 15) in control to 10.0 ± 3.6 (n = 12, t-test, two popula-
tions **p < 0.01) in 10 μM SKF 81297. Although not statis-
tically significant, there appeared to be also a decrease in
the peak of the first action potential from 38.4 ± 10.4 mV
(n = 15) in control to 33.2 ± 7.3 mV (n = 12, t-test, two
populations, p = 0.137) in 10 μM SKF 81297; a decrease in
the maximum upstroke velocity of the first action po-
tential from 87.0 ± 31.9 V/sec (n = 15) in control to 77.8 ±
35.2 V/sec (n = 12, t-test, two populations, p = 0.484) in10 μM SKF 81297; a decrease in the firing frequency from
33.1 ± 7.5 Hz (n = 15) in control to 29.9 ± 13.8 Hz (n = 12,
t-test, two populations, p = 0.459) in 10 μM SKF 81297
(Figure 6C). Taken together, these results suggest that acti-
vation of D1/D5 dopamine receptors induces substantial
changes in the intrinsic excitability of small DRG neurons
and reduces their ability to sustain volleys of action poten-
tials in response to current injection.
Expression of dopamine receptors in small DRG neurons
Our electrophysiology data strongly suggest that the ef-
fect of dopamine on TTX-R sodium current in small
DRG neurons is mediated by activation of D1/D5 dopa-
mine receptors, without any significant contribution of
D2 dopamine receptors. To further test this hypothesis,
we characterized the expression of D1, D2, and D5
dopamine receptors in DRG neurons. Relative tissue ex-
pression levels of D1, D2, and D5 dopamine receptor
subtypes were evaluated by Western blotting. Surpris-
ingly, levels of D1 and D5 dopamine receptors were sub-
stantially higher in dorsal root ganglia compared to
striatum, cortex, or lumbar spinal cord. In contrast, D2
dopamine receptors were undetected in dorsal root
ganglia but, highly enriched in striatum and cortex
(Figure 7). Immunofluorescence imaging of dissociated
DRG neurons showed that nearly all small DRG neurons
(diameter ≤ 30 μm), both isolectin B4 positive [IB4(+)]
and IB4(−) neurons, expressed D1 and D5 dopamine re-
ceptors. In contrast, most DRG neurons with diameter ≥
30 μm were only faintly stained (Figure 8). While some
plasma membrane staining was observed in small DRG
neurons, most of the immunofluorescence signal was
intracellular, apparently vesicular. The immunofluores-
cence results from fixed dissociated primary cultures
were confirmed in fixed dorsal root ganglia sections
(Figure 9). D1 and D5 dopamine receptors were prima-
rily expressed in smaller DRG neurons. The intensity
varied among the smaller neurons and no clear pattern
of IB4(+) or IB4(−) association emerged. Although the
immunofluorescence signals for D1 and D5 dopamine
receptors in the larger IB4(−) neurons were above back-
ground, the overall intensities were much lower than
those in smaller diameter neurons.
Discussion
The data presented here show a strong inhibition of
TTX-R sodium current in DRG neurons by activation of
D1/D5 dopamine receptors, accompanied by decrease
in their intrinsic excitability. Only small DRG neurons
(diameter of 24.8 ± 2.6 μm and cell capacitance of 19.5 ±
4.4 pF, n = 111) sensitive to capsaicin were included in the
study, and among those about 88% were also IB4(+). All
these features suggest that the dopamine-sensitive neu-






































Figure 5 Effect of SKF 81297 on the steady-state activation and inactivation curves of TTX-R sodium channels. A) Voltage-dependence
activation of TTX-R sodium channels. TTX-R voltage-gated sodium currents were elicited by 500 msec steps from a holding potential of – 80 mV
to voltages between −120 and + 30 mV in 10 mV increments. B) Voltage-dependence of inactivation of TTX-R sodium channels. TTX-R voltage-
gated sodium currents were elicited with a test pulse to −10 mV preceded by 500 msec prepulses from −120 to + 30 mV in 10 mV increments.
C) Collected results showing the effect of 10 μM SKF 81297 on the steady-state activation curve of TTX-R sodium channels in small DRG neurons
(diameter≤ 25 μm). The steady-state activation curve had a midpoint for activation of −15.1 ± 4.2 mV and a slope of 5.0 ± 1.8 mV (n = 17) in
control (circles) versus −12.7 ± 7.4 mV (t-test, two populations, p = 0.270) and 4.9 ± 2.1 mV (n = 15) in neurons incubated for 15 min in 10 μM SKF
81297 (diamonds). Dotted lines are best fits to the Boltzmann function. Error bars were omitted for clarity. D) Collected results showing the effect
of 10 μM SKF 81297 on the steady-state inactivation curve of TTX-R sodium channels (same neurons as in C). The steady-state inactivation curve
had a midpoint for inactivation of −34.7 ± 3.2 mV and a slope of 4.9 ± 1.1 mV (n = 17) in control (circles) versus −31.3 ± 4.2 mV (t-test, two
populations, *p < 0.05) and 5.2 ± 1.9 mV (n = 15) in 10 μM SKF 81297 (diamonds). Dotted lines are best fits to the Boltzmann function. Error bars
were omitted for clarity.
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firmed the expression of D1 and D5 dopamine receptors
in dorsal root ganglia, but no evidence was found for
the expression of D2 dopamine receptors. These results
were consistent with those obtained with electrophysi-
ology in which the D2 agonist quinpirole had little effect.
Using polymerase chain reaction (PCR) and DNA se-
quencing, transcripts of D1-D5 dopamine receptors, in-
cluding D2 dopamine receptors, have been reported in
dorsal root ganglia [30,31]. A possible explanation for
this discrepancy could be that, even though the trans-
cript for D2 dopamine receptors is detectable with PCR,
the protein level could be too low to be detected by
Western blotting or immunofluorescence microscopy.
Alternatively, it is possible that once translated into
protein, D2 dopamine receptors are rapidly transportedfrom the cell body to the terminals, and thus are missed
with our analysis.
In most DRG neurons, the inhibitory effects of dopa-
mine or SKF 81297 on TTX-R sodium current required
many minutes to develop fully. In most of the neurons
tested, the inhibitory effect of the drug did not reach a
steady-state even after 15 min. This is slower than the
inhibitory effect of dopamine on TTX-S sodium current
in hippocampal or prefrontal cortex neurons [58,59], but
similar to that in retinal ganglion cells [66]. The relative
slow development of inhibition is consistent with me-
diation by a second messenger pathway involving PKC.
Activation of PKA or PKC has been reported to mo-
dulate NaV1.8 channels in DRG neurons with increases
in current amplitude and changes in the kinetic proper-
ties [60-62]. Our results (Figure 4A) suggest that PKA
Figure 6 Effect of SKF 81297 on the firing properties of small DRG neurons. A) Top: current clamp protocol: 0.8 sec ramp of current to
1 nA was injected to elicit action potentials. Bottom: action potentials elicited in a small DRG neuron (diameter≤ 25 μm) in control. B) Action
potentials elicited in a different small DRG neuron (diameter≤ 25 μm) incubated for 15 min in 10 μM SKF 81297. C) In collected results, the total
number of action potentials during the first current injection decreased from 14.9 ± 3.4 (n = 15) in control to 10.0 ± 3.6 (n = 12) in 10 μM SKF
81297 (t-test, two populations **p < 0.01); the peak of the first action potential decreased from 38.4 ± 10.4 mV (n = 15) in control to 33.2 ± 7.3 mV
(n = 12) in 10 μM SKF 81297 (t-test, two populations, p = 0.137); the maximum upstroke velocity of the first action potential decreased from
87.0 ± 31.9 V/sec (n = 15) in control to 77.8 ± 35.2 V/sec (n = 12) in 10 μM SKF 81297 (t-test, two populations, p = 0.484); the firing frequency
decreased from 33.1 ± 7.5 Hz (n = 15) in control to 29.9 ± 13.8 Hz (n = 12) in 10 μM SKF 81297 (t-test, two populations, p = 0.459).
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current by D1/D5 dopamine receptor activation, in con-
trast with results in central neurons where activation of
D1/D5 dopamine receptors inhibits the TTX-S sodium
current through activation of PKA [57-59].
The reduced effect of SKF 81297 on TTX-R sodium
current when blocking PKC (Figure 4C) strongly sug-
gests that PKC activity is required for modulation of
TTX-R sodium current upon activation of D1/D5 dopa-
mine receptors. Activation [61,63,64] or inhibition [61]
of PKC has been reported to up-regulate or down-
regulate, respectively, the TTX-R sodium current in
small DRG neurons. Even though multiple mechanisms/
pathways are required to explain the full actions of PKC
on TTX-R sodium current, the reduced effect of SKF
81297 on the TTX-R sodium current observed in our
experiments is more consistent with inhibition of PKC
activity upon activation of D1/D5 dopamine receptors.
Additional experiments are needed to better characterizethe intracellular pathway downstream to D1/D5 dopa-
mine receptor activation in small DRG neurons.
The stimulation of D1/D5 dopamine receptors re-
duced the excitability of small DRG neurons, as mani-
fested in reduction of action potential firing, and a
decrease in the peak and the maximum upstroke velocity
of action potentials. These effects are consistent with in-
hibition of TTX-R (NaV1.8) current, the main current re-
sponsible for the upstroke of the action potential in
DRG neurons [14,22,23]. It is also likely, however, that
D1/D5 dopamine receptor activation can modulate other
ion channels critical to action potential generation in
DRG neurons. Whether this could account for the
changes observed here is unknown and will require fur-
ther experiments.
Many observations support the idea that dopamine
may be released locally in the dorsal root ganglia: i) TH,
the rate-limiting enzyme for the synthesis of catecho-
lamines, is expressed in about 8-10% of DRG neurons
AB
Figure 7 Western blotting of dopamine receptors. Immunoblots for D1, D2, and D5 dopamine receptors were obtained for frontal cortex
(CTX), striatum (STM), spinal cord (SC) and dorsal root ganglia (DRG) proteins. All wells were loaded with the same concentration of total protein
with GAPDH serving as an internal control. A) Membranes were probed with antibodies specific for D1, D2, or D5 dopamine receptors. D1 and
D5 were identified in CTX, STM, and DRG as single bands with apparent MW’s of 68 kDa. D2 dopamine receptor protein was identified in CTX
and STM as a single band with an apparent MW of 62 kDa. Corresponding sections from each blot were probed with antibody against GAPDH
(shown beneath the membranes in A). B) Western blotting of D1 and D5 dopamine receptors were repeated comparing equal concentrations of
SC and DRG protein. Corresponding sections from each blot were probed with antibody against GAPDH (shown beneath the membranes in B).
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droxyphenylacetic acid (DOPAC) and homovanillic acid
(HVA) have been detected in DRG neurons and in dor-
sal spinal nerve roots, but not in satellite and Schwann




Figure 8 Expression of dopamine receptors in acutely isolated DRG n
formaldehyde, permeabilized, blocked and then probed with lectin FITC-lab
receptors antibodies (red channel, B) and secondary antibodies against mo
co-localization of IB4 and either D1 or D5 dopamine receptors (yellow). Scadopamine, dopamine release could be evoked by high
potassium stimulation and detected by amperometric
means, suggesting that DRG neurons may carry the ne-
cessary release machinery for dopamine [49]. A question
however remains why previous work has failed to detectMerge
Merge
eurons. Acutely dissociated DRG neurons were fixed in 4%
eled IB4 (green channel) or D1 (red channel, A) or D5 dopamine
use IgG labeled with Alexa 594. Merging the images indicated some




Figure 9 Expression of dopamine receptors in intact dorsal root ganglia. Frozen sections, 20 μm thick, were prepared from lumbar DRG
taken from P14 to P28 Sprague Dawley rats perfused with formaldehyde. Sections of dorsal root ganglia were stained with FITC-labeled lectin IB4
(green channel) and monoclonal antibodies to either D1 (red channel, A) or D5 dopamine receptors antibodies (red channel, B), and secondary
antibodies against mouse IgG labeled with Alexa 594. Merging the images indicated some co-localization of IB4 and either D1 or D5 dopamine
receptors (yellow). Scale bars are 50 μm.
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(AADC) and dopamine β-hydroxylase (DBH), involved
in the synthesis of catecholamines [40,44,73,74], even
though in some cases AADC and DBH have been de-
tected in TH(−) DRG neurons [44]. A possible expla-
nation for this discrepancy could be that the protein
levels of AADC and DBH are too low to be detected by
immunocytochemistry. Alternatively, it is possible that
TH(+) DRG neurons may synthesize L-DOPA, which
after release is converted to dopamine by AADC loca-
lized in other cell types.
In other sensory systems, including the retina and the
olfactory bulb, spontaneously active dopaminergic cells
provide a tonic release of dopamine [75-78], which plays
an important function in sensory adaptation. In the ret-
ina, dopamine sets the gain of the retinal networks for
vision in bright light [79]. Similarly, in the olfactory bulb,
dopamine plays an important function in setting the gain
for odor discrimination [80-84]. TH(+) DRG neurons
form a selective class of unmyelinated Low-Threshold
mechanoreceptors (C-LTMRs) innervating hair follicles
in the skin [41] and associated with light touch and
injury-induced mechanical hypersensitivity [85,86]. TH(+)
C-LTMRs are not spontaneously active, but in response to
light mechanical force they respond with a train of action
potentials [41] that can trigger dopamine release. Light
touch able to induce stretch of the skin or deflection of
hair follicles able to activate C-LTMRs is a very frequent
experience during the daily activity, supporting the possi-
bility that TH(+) C-LTMRs may release dopamine in the
dorsal root ganglia very frequently. Thus, increasing or de-
creasing levels of dopamine in the dorsal root ganglia mayserve to adjust the sensitivity of nociceptors to noxious
stimuli, with increasing levels of dopamine raising the
threshold for pain and reduced levels increasing the sen-
sitivity to noxious stimuli. Future behavioral experi-
ments using animal models of pain are needed to test
this hypothesis.
Conclusions
In summary, our results demonstrate that DRG neurons
express D1 and D5 dopamine receptors, but not D2
dopamine receptors. Agonists of D1/D5 dopamine re-
ceptors cause robust inhibition of TTX-R sodium cur-
rent in small DRG neurons and decrease their ability to
fire action potentials in response to stimulus. A func-
tional implication of the inhibitory effect of dopamine
could be that, by modulating the TTX-R sodium current
and the intrinsic excitability of DRG neurons, increasing
or decreasing levels of dopamine may adjust the sensiti-
vity of nociceptor sensory neurons to incoming sensory
stimuli.
Materials and methods
Preparation of isolated Dorsal Root Ganglia neurons
Isolated DRG neurons were prepared from Sprague
Dawley rats, postnatal day 14–28. Animal were anesthe-
tized with isoflurane and decapitated. Both thoracic and
lumbar segments of the spinal cord were removed and
placed in a cold Ca2+, Mg2+-free Hank’s solution con-
taining (in mM) 137 NaCl, 5.3 KCl, 0.33 Na2HPO4, 0.44
KH2PO4, 5 HEPES, 5.5 Glucose, pH = 7.4 with NaOH.
The bone surrounding the spinal cord was removed and
dorsal root ganglia were exposed and pulled out. After
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incubated for 20 min at 34°C in Ca2+, Mg2+-free Hank’s
solution containing 20 U/ml Papain (Worthington
Biochemical, Lakewood, NJ) and 5 mM D,L-cysteine.
Ganglia were washed and incubated for 20 min at 34°C
in Ca2+, Mg2+-free Hank’s solution containing 3 mg/ml
collagenase (Type I, Sigma-Aldrich, St. Louis, MO) and
4 mg/ml Dispase II (Boehringer Mannheim, Indianapolis,
IN). Ganglia were then placed in Leibovitz’s L-15 medium
(Invitrogen, San Diego, CA) supplemented with 10% fetal
calf serum, 5 mM HEPES, and 50 ng/ml NGF (Invitrogen,
San Diego, CA). Individual cells were dispersed by mech-
anical trituration using fire-polished Pasteur pipettes with
decreasing bore size and plated on glass coverslip treated
with 30–50 μg/ml poly-D-lysine. Cells were incubated in
the supplemented L-15 solution at 34°C (in 5% CO2) for
2 hours, then stored at room temperature in Neurobasal
medium (Gibco) and used over the next 4–6 hours. This
protocol yields spherical cell bodies without neurites,
which enhances voltage control of sodium current. The
cells can be lifted from the cover slip after establishing the
whole-cell configuration in order to facilitate rapid solu-
tion changes using flow pipes.
Western blotting
Immunoblots were performed for D1, D2 and D5 dopa-
mine receptor proteins in dorsal root ganglia, frontal
cortex, striatum and spinal cord of P14 to P28 Sprague
Dawley rats. Animals were euthanized and perfused with
heparinized saline. The dissected nervous tissue samples
were immediately frozen on dry ice and stored at −80°C.
Proteins were extracted from the frozen samples with
ice cold lysis buffer prepared with complete EDTA-free
protease inhibitor cocktail tablets (Roche Pharmaceuti-
cals), 20 mM Tris, 150 mM NaCl, 2.5 mM Na4P2O7, 1%
Nonidet P40, 0.1% SDS and 1 mM of EDTA, NaF, PMSF,
Na3VO4, and dithiothrietol. Three 2.3 mm diameter Zir-
cona/Silica beads (Biospec) were added to the samples
which were then homogenized in a Biospec Mini Bead
Beater for one min. Samples were centrifuged at 4°C at
13,000 × g for 15 min and the supernatant fluids were
saved. Total protein concentrations were determined
using Bio Rad Protein Assay Dye Reagent Concentrate.
After the addition of concentrated Laemmli buffer and
heating to 80°C, equal amounts of total protein were
subjected to SDS PAGE in a 10% polyacrylamide gel and
transferred to PVDF membrane in a Semi-Dry Blot ap-
paratus (BioRad). Membranes were blocked overnight
with 5% non-fat milk in TBS at 4°C and probed with D1
(Millipore MAB5290), D2 (Millipore AB5084P) or D5
(Millipore MAB5292) dopamine receptor antibodies at
1:500 with 5% non-fat milk in TBS for 3 h. Internal
control GAPDH antibody (Sigma G8795) was incubated
at 1:5000 with 5% non-fat milk in TBS for 1 h. Afterprimary antibody incubation, membranes were washed
3 times with 0.05% Tween-20 in Tris-buffered saline
(TBS-T) for 10 min each wash. Secondary antibodies
linked to HRP were diluted 1:8000 (Santa Cruz, L0312)
and 1:5000 (Santa Cruz, L1911) with 5% non-fat milk in
TBS and incubated with the washed membranes for 2 h at
room temperature. Membranes were then washed 3 times
with TBS-T as described above and then antibody binding
was detected with ECL plus reagent (GE).
Immunocytochemistry
Indirect immunofluorescence was used to assess expres-
sion of the receptor subtypes in dissociated DRG neu-
rons in primary culture. DRG neurons were fixed with
4% formaldehyde in Hank’s Buffered Saline Solution
(HBSS) for 20 min, washed 3 times in PBS, 10 min each,
and then permeabilized with 0.2% Nonidet P40 in TBS
for 20 minutes. After 3 more washes with TBS, 10 min
each, cover slips were blocked for 1 h with blocking
solution (10% Goat Serum, 1% BSA in TBS) and then
probed with primary dopamine receptor antibody over-
night in blocking solution (1:500), followed by secondary
antibody (1:1000 Invitrogen Alexa Fluor 594 A11032)
with or without FITC-labeled lectin IB4 for 1.5 h at
room temperature. Following 3 washes with TBS, the
coverslips were rinsed with deionized water and then
mounted (Prolong Gold Antifade mounting fluid) on
Superfrost Plus microscope slides (Fisher) and imaged
with a confocal microscope (Olympus Fluoview1000).
For fixed tissue specimens, P14 to P28 Sprague Dawley
rats were euthanized and perfused with heparinized
saline, followed by 4% formaldehyde in PBS. Dissected
specimens were then post fixed for 30 min in 4% for-
maldehyde in PBS before being transferred to a solution
of 30% sucrose in PBS for overnight incubation at 4°C.
Fixed tissues were embedded in optimum cutting tempe-
rature compound (OCT), frozen on dry ice and then
sliced into 20 μm thick sections with a cryostat (Leica)
and collected onto Superfrost Plus microscope slides. As
soon as dry, the sections were stored up to several days
at −20°C. Before the addition of antibody, the sections
were permeabilized and blocked with 10% goat serum in
TBS with 0.1% Nonidet P40 for 3 h at room tempe-
rature. Specimens were then probed with primary anti-
body overnight in 10% goat serum in TBS at 4°C. They
were then washed 3 times in TBS-T and then incubated
with fluorescently labeled secondary antibody (1:1000
Invitrogen Alexa Fluor 594 A11032) diluted with 10%
goat serum and 1% rat serum in TBS with or without
FITC-labeled IB4 for 2 h at room temperature. The wash
steps were repeated. The slides were rinsed with deio-
nized water and thoroughly drained. A drop of moun-
ting fluid was placed on each section and coverslips
were mounted. All slides were imaged on a confocal
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tained with a 40× oil objective and 1.4 NA lens. All
images were exported as TIFF files to Image J, which
was used to process the final images.
Cell classification
Small DRG neurons (cell diameter ≤ 25 μm) were chosen
for recording. At the end of each experiment, the re-
corded DRG neuron was tested for the expression of
TRPV1 channels (by testing the sensitivity to 1 μM cap-
saicin) and classified as nociceptor or non-nociceptor
[87]. As nociceptors are neurochemically and function-
ally distinct [69,70,88,89], a further classification was
made by testing the ability of TRPV1-positive DRG neu-
rons to bind the isolectin B4 (IB4) FITC conjugate and
classified as peptidergic [IB4(−)] or non-peptidergic [IB4
(+)]. Overall about 75-80% of small DRG neurons tested
were sensitive to capsaicin and only those were included
in this study. Of the neurons sensitive to capsaicin,
about 88% were also IB4(+). Small DRG neurons with
these properties are considered to be nociceptive neu-
rons [67-70].
Electrophysiology
Whole-cell recordings were made with a Multiclamp
700B amplifier (Molecular Devices, Sunnyvale, CA). Patch
pipettes were pulled from borosilicate glass (100 μl micro-
capillaries, VWR, South Plainfield, NJ) or A-M Systems
glass 8250 (A-M Systems, Sequim, WA) using a Sutter
P97 puller (Sutter Instrument, Novato, CA). The resis-
tance of the patch pipette was 1.8-2.5 MΩ when filled
with the standard internal solution. The tips of the patch
pipettes were wrapped with Parafilm to reduce pipette
capacitance. In whole-cell mode the capacity current was
reduced by using the amplifier circuitry. Series resistance
was 3.2 ± 0.8 MΩ (n = 122) when the patch pipette was
filled with Cs-based internal solution for voltage clamp
experiments, and 5.0 ± 1.4 MΩ (n = 27) when the patch
pipette was filled with K-based internal solution for cur-
rent clamp experiments. To reduce voltage errors, 70-80%
of series resistance compensation was applied. In voltage
clamp experiments a Cs-based internal solution was used
to block outward currents through potassium channels.
This solution contained (in mM): 125 CsCl, 10 NaCl,
2 MgCl2, 10 EGTA, 10 HEPES, 14 Tris-creatine PO4,
4 Mg-ATP, and 0.3 Na-GTP, pH = 7.2 with CsOH. In the
experiments in Figure 5, 20 mM CsCl were replaced with
20 mM Tetraethylammonium-Cl to block outward cur-
rent at depolarized potentials. In current clamp experi-
ments a K-based internal solution was used. This solution
contained (in mM): 135 K-methanesulfonate, 10 NaCl,
2 MgCl2, 0.1 EGTA, 10 HEPES, 14 Tris-creatine PO4,
4 Mg-ATP, and 0.3 Na-GTP, pH= 7.2 with KOH. Seals
were formed in Tyrode’s solution containing (in mM):151 NaCl, 2.5 KCl, 2 CaCl2, 10 HEPES, 13 glucose,
pH = 7.4 with NaOH. After the whole-cell configuration
had been established, cells were lifted off in front of an
array of gravity-fed quartz flow pipes (I.D. 320 μm) that
allowed rapid (<1 sec) exchange of external solutions. To
isolate the TTX-R sodium current, the Tyrode’s solution
was supplemented with 300 nM TTX and 30 μM CdCl2
in order to block the TTX-S sodium current and cal-
cium current, respectively. The concentration of TTX
used (300 nM) is sufficient to fully block the TTX-S
sodium current while sparing the TTX-R sodium current,
which requires about 40 μM for half-block [3,4,90]. Simi-
larly, the amount of Cd2+ used (30 μM) to block the
calcium current should have only minimal effect on the
TTX-R sodium current [3,91,92].
Expression of TRPV1 channels in small DRG neurons
was tested at the end of each experiment by challenging
the neuron with 1 μM capsaicin and neurons were clas-
sified as TRPV1 positive if the inward current activated
by capsaicin at – 80 mV reached at least −500 pA.
Data acquisition and analysis
Currents and voltages were controlled and sampled
using a Digidata 1440 A interface and pClamp 10 soft-
ware (Molecular Devices, Sunnyvale, CA). Current or
voltage signals were filtered at 10 kHz (−3 dB, 4-pole
Bessel) and digitized at 50 kHz. Analysis was performed
using pClamp 10 and Igor Pro (version 6, Wavemetrics,
Lake Oswego, OR), using DataAccess (Bruxton, Seattle,
WA) to import pClamp files in Igor. Small DRG neurons
(diameter 18 to 25 μm) were initially selected by meas-
uring the diameter from images captured to computer
by a CCD camera Oly-150 (Olympus Imaging America
Inc., Center Valley, PA) using a video acquisition card
(dP dPict Imaging, Inc., Indianapolis, IN). A more accu-
rate measurement of cell diameter was obtained from
measurements of whole-cell capacitance assuming a
membrane capacitance of 1 μF/cm2 and spherical shape.
Cell capacitance was measured by integrating the average
of 5–10 current responses to a – 5 mV step from −80 mV
filtered at 10 KHz and acquired at 50 KHz. In Figure 5,
conductance (G) was measured as G= I/(V-Vres), where I
is the peak current, V is the voltage, and Vres is the re-
versal potential for sodium current. Vres (67.4 ± 2.7 mV,
n = 13) was measured with series of steps from −100 to +
100 mV, increments of 10 mV. G is plotted normalized to
Gmax, the peak conductance. The lines are best fits to the
Boltzmann function: 1/(1 + exp[−(V-V1/2)/k]), where V is
the step membrane potential in millivolts,V1/2 is the half-
maximal voltage in millivolts, and k is the slope factor in
millivolts. Sodium channels availability was determined by
using 500 msec prepulses from −120 to + 30 mV followed
by a test pulse to −10 mV. The test pulse current is nor-
malized to its maximal value. Solid lines are best fits to
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is the prepulse membrane potential, V1/2 is the half-
maximal voltage, and k is the slope factor in millivolts. In
current clamp experiments, reported voltages were cor-
rected for the – 8 mV junction potential between the po-
tassium methanesulfonate-based internal solution and the
Tyrode’s solution present when zeroing pipette current.
The junction potential was measured using a flowing 3 M
KCl bridge [93]. Action potentials were elicited by inject-
ing 0.8 sec ramps of current to 1 nA [56]. Usually action
potential firing began within 150–200 msec. The peak of
the first action potential was quite positive (average +
38 mV), but gradually decreased during current injection
until only oscillations were observed. Only action po-
tentials that had a peak ≥ 0 mV and amplitude (from
peak to trough) of ≥ 30 mV were included in the analysis.
All experiments were carried out at room temperature
(22 ± 2°C). Data are reported as Mean ± SD. Statistical dif-
ferences between data sets were analyzed using the t-test
or one-way ANOVA, followed by post-hoc Dunnett ana-
lysis (for the data sets in Figure 3B). Differences were con-
sidered significant at *p < 0.05 or **p < 0.01.
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